Sign in
CompletedNo phase

Maternal Opioid Treatment: Human Experimental Research - Data Yield Appropriate Decisions

Key facts

Who runs it
University of Vermont
Where
Asheville, Burlington, Chapel Hill, and Richmond, United StatesSee the 4 sites
Trial code
Status
Completed
People taking part
88 people enrolled
Started
8 Aug 2019
Ended
1 Feb 2024
Type of study
Observational, 2 groups
Treatments tested
  • Medically-supervised withdrawal
  • Opioid agonist treatment
  • Comprehensive clinical care
Record updated
8 February 2024

Who can take part

Age
18 years to 41 years
Sex
Women only
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • Be ages 18 to 41, inclusive
  • Have a single fetus pregnancy between 6-30 weeks estimated gestational age
  • Willing to participate in the study

Who cannot take part

  • Non-English speaking

Where in United States

  • Mountain Area Health Education CenterAsheville, United States
  • University of VermontBurlington, United States
  • UNC Chapel Hill HorizonsChapel Hill, United States
  • Virginia Commonwealth UniversityRichmond, United States

About the trial

What the trial wants to find out

This study will compare medically-supervised withdrawal (MSW, 'detoxification') to opioid agonist treatment (OAT, 'maintenance') with buprenorphine for pregnant women with opioid use disorder in terms of maternal, fetal, and neonatal outcomes. Outcomes will be assessed during pregnancy, at birth and for 12 months postpartum. This study has the potential to impact health service policy and practices in terms of the treatment options of pregnant women with opioid use disorder.

The 2 groups in the trial

  • Medically-supervised withdrawal (MSW)

    Treatment: Medically-supervised withdrawal and Comprehensive clinical care

  • Opioid agonist treatment (OAT)

    Treatment: Opioid agonist treatment and Comprehensive clinical care

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Medically-supervised Withdrawal vs. Agonist Maintenance in the Treatment of Pregnant Women With Opioid Use Disorder: Maternal, Fetal, and Neonatal Outcomes
Record updated
8 February 2024